Caris Life Sciences
Updates & Highlights
MarketBeat · 2 days ago
Lazard Asset Management LLC Raises Stock Holdings in Caris Life Sciences, Inc. $CAI
MarketBeat · 5 days ago
Caris Life Sciences, Inc. $CAI Stake Lessened by Rock Springs Capital Management LP
Moomoo · 10 days ago
BTIG Maintains Caris Life Sciences(CAI.US) With Buy Rating, Maintains Target Price $32
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Caris Life Sciences?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentLazard Asset Management LLC Raises Stock Holdings in Caris Life Sciences, Inc. $CAI
Lazard Asset Management LLC Raises Stock Holdings in Caris Life Sciences, Inc. $CAI
MarketBeat · 2 days ago
Caris Life Sciences, Inc. $CAI Stake Lessened by Rock Springs Capital Management LP
Caris Life Sciences, Inc. $CAI Stake Lessened by Rock Springs Capital Management LP
MarketBeat · 5 days ago
BTIG Maintains Caris Life Sciences(CAI.US) With Buy Rating, Maintains Target Price $32
BTIG Maintains Caris Life Sciences(CAI.US) With Buy Rating, Maintains Target Price $32
Moomoo · 10 days ago
Caris Life Sciences Has Fallen 63% From Its High Ahead of August 5 Earnings. Is the Selloff Overdone?
Caris Life Sciences Has Fallen 63% From Its High Ahead of August 5 Earnings. Is the Selloff Overdone?
TIKR.com · 11 days ago
Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More
Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More
Yahoo Finance · 12 days ago
Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection (NASDAQ:CAI)
Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection (NASDAQ:CAI)
Seeking Alpha · 12 days ago
Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists
Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists
simplywall.st · 16 days ago
Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists
Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists
simplywall.st · 16 days ago
Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval
Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval
Yahoo Finance · 16 days ago
Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump
Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump
Yahoo Finance · 16 days ago
Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?
Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?
Yahoo Finance · 16 days ago
Caris Life Sciences to report Q2 2026 results on August 5
Caris Life Sciences to report Q2 2026 results on August 5
scanx.trade · 17 days ago
Caris Life Sciences Sets 3:30 p.m. CT Webcast for Aug. 5
Caris Life Sciences Sets 3:30 p.m. CT Webcast for Aug. 5
Stock Titan · 17 days ago
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Morningstar · 17 days ago
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Yahoo Finance · 17 days ago
Caris Life Sciences adds PTEN testing for prostate cancer
Caris Life Sciences adds PTEN testing for prostate cancer
Investing.com · 19 days ago
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
PR Newswire · 19 days ago
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Yahoo Finance · 19 days ago
Caris Life Sciences, Inc. Stock 12‑Month Price Target Cut to $27.08, Implies 59% Upside
Caris Life Sciences, Inc. Stock 12‑Month Price Target Cut to $27.08, Implies 59% Upside
TradingView · 20 days ago
Insider Buying: Caris Life Sciences (NASDAQ:CAI) Director Acquires $990,080.00 in Stock
Insider Buying: Caris Life Sciences (NASDAQ:CAI) Director Acquires $990,080.00 in Stock
MarketBeat · 20 days ago